View in EDS HTML Full Text PDF Full Text

The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure.

Saved in:
Bibliographic Details
Title: The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure.
Authors: Krens SD; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Lubberman FJE; Department of Pharmacy, Ziekenhuis Gelderse Vallei, Ede, The Netherlands., van Egmond M; Department of Clinical Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands., Jansman FGA; Department of Pharmacy, Deventer Hospital, Deventer, The Netherlands.; PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands., Burger DM; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Hamberg P; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Vervenne WL; Department of Medical Oncology, Deventer Hospital, Deventer, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., van Erp NP; Department of Clinical Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
Source: International journal of cancer [Int J Cancer] 2021 Jun 01; Vol. 148 (11), pp. 2799-2806. Date of Electronic Publication: 2021 Jan 19.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33428771
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Krens+SD%22">Krens SD</searchLink>; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lubberman+FJE%22">Lubberman FJE</searchLink>; Department of Pharmacy, Ziekenhuis Gelderse Vallei, Ede, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Egmond+M%22">van Egmond M</searchLink>; Department of Clinical Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jansman+FGA%22">Jansman FGA</searchLink>; Department of Pharmacy, Deventer Hospital, Deventer, The Netherlands.; PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Burger+DM%22">Burger DM</searchLink>; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hamberg+P%22">Hamberg P</searchLink>; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vervenne+WL%22">Vervenne WL</searchLink>; Department of Medical Oncology, Deventer Hospital, Deventer, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gelderblom+H%22">Gelderblom H</searchLink>; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Graaf+WTA%22">van der Graaf WTA</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Desar+IME%22">Desar IME</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Herpen+CML%22">van Herpen CML</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Erp+NP%22">van Erp NP</searchLink>; Department of Clinical Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220042124%22">International journal of cancer</searchLink> [Int J Cancer] 2021 Jun 01; Vol. 148 (11), pp. 2799-2806. <i>Date of Electronic Publication: </i>2021 Jan 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0042124 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200207136%22">00207136 </searchLink><i>NLM ISO Abbreviation: </i>Int J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33428771
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ijc.33469
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2799
    Titles:
      – TitleFull: The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Krens SD
      – PersonEntity:
          Name:
            NameFull: Lubberman FJE
      – PersonEntity:
          Name:
            NameFull: van Egmond M
      – PersonEntity:
          Name:
            NameFull: Jansman FGA
      – PersonEntity:
          Name:
            NameFull: Burger DM
      – PersonEntity:
          Name:
            NameFull: Hamberg P
      – PersonEntity:
          Name:
            NameFull: Vervenne WL
      – PersonEntity:
          Name:
            NameFull: Gelderblom H
      – PersonEntity:
          Name:
            NameFull: van der Graaf WTA
      – PersonEntity:
          Name:
            NameFull: Desar IME
      – PersonEntity:
          Name:
            NameFull: van Herpen CML
      – PersonEntity:
          Name:
            NameFull: van Erp NP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2021 Jun 01
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0215
          Numbering:
            – Type: volume
              Value: 148
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: International journal of cancer
              Type: main
ResultId 1